<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H9DB5895CA33B4FF1AAD4A6A1BC1599D7" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 8018 IH: Increase Support for Life-saving Endocrine Transplantation Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2026-03-19</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 8018</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20260319">March 19, 2026</action-date><action-desc><sponsor name-id="N000190">Mr. Norman</sponsor> (for himself and <cosponsor name-id="B001298">Mr. Bacon</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To regulate human cadaveric islets for transplantation as organs.</official-title></form><legis-body id="HDA52C611B66D4C40949A089CB2E8D030" style="OLC"> 
<section section-type="section-one" id="HF810F38254FC439691BB79F8441BD728"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Increase Support for Life-saving Endocrine Transplantation Act</short-title></quote> or the <quote><short-title>ISLET Act</short-title></quote>.</text></section> <section commented="no" display-inline="no-display-inline" id="H7027514C6DC442F2A01B3E9D90DD33F7"><enum>2.</enum><header>Regulation of human cadaveric islet transplants</header> <subsection commented="no" display-inline="no-display-inline" id="H705690E0C09D474BA0796804C5538274"><enum>(a)</enum><header display-inline="yes-display-inline">In general</header><text display-inline="yes-display-inline">Section 374(d)(2) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/274b">42 U.S.C. 274b(d)(2)</external-xref>) is amended by striking <quote>pancreas,</quote> and inserting <quote>and pancreas, human cadaveric islets,</quote>.</text></subsection>
<subsection commented="no" display-inline="no-display-inline" id="H9186A70DABF54CB39048532DC12F98C8"><enum>(b)</enum><header>Clarification</header><text>Notwithstanding any other provision of law, none of the following terms includes human cadaveric islets:</text> <paragraph commented="no" display-inline="no-display-inline" id="HE4D110E1D77F4AB89B44316DFFB4FF56"><enum>(1)</enum><text display-inline="yes-display-inline">The term <term>drug</term>, as defined in section 201(g) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/321">21 U.S.C. 321(g)</external-xref>).</text></paragraph>
<paragraph commented="no" display-inline="no-display-inline" id="H23675F4287F64796BC15B147270128DF"><enum>(2)</enum><text display-inline="yes-display-inline">The term <term>biological product</term>, as defined in section 351(i) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/262">42 U.S.C. 262(i)</external-xref>).</text></paragraph> <paragraph commented="no" display-inline="no-display-inline" id="H553A6DFEF4DA437283BC12C2F4BD2DB2"><enum>(3)</enum><text>The term <term>human cells, tissues, or cellular or tissue-based products (HCT/Ps)</term>, as defined in section 1271.3 of title 21, Code of Federal Regulations (or any successor regulations).</text></paragraph></subsection>
<subsection id="H27DB6CE8FEB6479185EC92F89948037A"><enum>(c)</enum><header>Regulations</header>
<paragraph commented="no" display-inline="no-display-inline" id="HBF0D01001E7340FC892D39B62CBECAD2"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the <quote>Secretary</quote>) shall update regulations promulgated under parts F, G, and H of title III of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/262">42 U.S.C. 262 et seq.</external-xref>, 264 et seq., 273 et seq.) and the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/301">21 U.S.C. 301 et seq.</external-xref>), and such other regulations as the Secretary determines appropriate, to carry out the amendment made by subsection (a).</text></paragraph> <paragraph commented="no" display-inline="no-display-inline" id="H3E5FE1C2189C411D86647176199A064C"><enum>(2)</enum><header>Report</header><text>Not later than 6 months after the date of enactment of this Act, the Secretary shall report to Congress on the progress made in updating regulations as required under paragraph (1).</text></paragraph></subsection></section> 
</legis-body></bill>

